Latest chairman's letter re exciting new products reads the same...

  1. 34 Posts.
    Latest chairman's letter re exciting new products reads the same as the 2003 report - all vague promises. In Dec 17 Dixon was enthusiastic about biologically active materials in pre filled syringes - products with much improved margins etc. This is all very misleading for investors/shareholders. This has the appearance that Medigard is stalling for some reason.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.